Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Remedy found a new CEO

REMEDYAnalyst Comment10.02.2026, 07.59
Atte RiikolaAnalyst
Discuss

Summary

  • Remedy announced the appointment of Jean-Charles Gaudechon as the new CEO, effective March 1, 2026, as the company enters a strategic development phase.
  • Gaudechon brings over 20 years of leadership experience in the global gaming industry, having held senior roles at Electronic Arts and CCP Games.
  • The company does not anticipate any fundamental changes to its strategy, as it transitions into a phase of profitable growth following years of investment.
  • Markus Mäki, the founder and interim CEO since October 2025, will continue in his role until March and will support Gaudechon thereafter.

This content is generated by AI. You can give feedback on it in the Inderes forum.

Translation: Original published in Finnish on 2/10/2026 at 7:35 am EET.

Remedy announced on Monday that the company's Board of Directors has appointed Jean-Charles Gaudechon as the company's new CEO, effective March 1, 2026. Gaudechon's profile appears to be well-suited to Remedy's strategic development phase, in which the company is currently preparing for significant game releases. We do not expect the CEO appointment to cause any fundamental changes to Remedy's strategy, as the company is now moving into a phase of profitable growth after years of investment.

Gaudechon has over 20 years of leadership experience in the global gaming and entertainment industry. He has previously held senior management positions at international gaming companies such as Electronic Arts and CCP Games, where he held full profit and loss responsibility. Markus Mäki, the company's founder, who has served as interim CEO since October 2025, will continue in his role until the beginning of March. Mäki will then continue to support the new CEO.

Remedy Entertainment is a game developer. Its operations are primarily focused on the development of action games, with a particular focus on 3D technology. Examples of games that the company has developed include several different versions of Alan Wake, Max Payne, and Control. Remedy also develops its own game engine and tooling technology that powers many of its games. The company was founded in 1995 and is headquartered in Espoo, Finland.

Read more on company page

Key Estimate Figures16.12.2025

202425e26e
Revenue50.758.7122.0
growth-%49.3 %15.9 %107.9 %
EBIT (adj.)-4.3-15.50.8
EBIT-% (adj.)-8.4 %-26.4 %0.6 %
EPS (adj.)-0.27-0.990.02
Dividend0.000.000.00
Dividend %
P/E (adj.)neg.neg.1,028.7
EV/EBITDA65.920.310.4

Forum discussions

It’s almost been a month since the launch of Control Resonant, and based on data and online chatter, the long tail of sales looks as expected...
2 hours ago
by Thiebault
3
https://www.gamestop.com/video-games/playstation-5/products/control-resonant-steelbook-edition---playstation-5/447323.html Steelbook up on GameStop...
2 hours ago
by Konamixx
1
Physical copies seem to have sold well in the UK Here are the best-selling titles for the week in the UK at retail: EA Sports FC 27 Control ...
5 hours ago
22
Returning to this excellent question once more. Digging through my notes based on the H1 2024 webcasts, I estimate that Remedy had around 230...
10/17/2026, 11:43 AM
28
Is even the standard edition of Resonant (PS5) sold out at Game UK? It had been at the #1 spot all week, but now it can’t be found on the bestseller...
10/16/2026, 5:50 PM
17
I am completely aligned with Akee regarding the forecasts. Everything really needs to hit the mark for it to reach 1.9 million. It’s more likely...
10/16/2026, 8:45 AM
by Relaaja
3
1.9M for this year is totally doable. You’re underestimating holiday sales. A lot of digital gifts are bought, and physical copies will definitely...
10/16/2026, 8:36 AM
by Jarnis
10